Related Experiment Video
Updated: Jun 22, 2026
08:43
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Mild Alzheimer's disease: a "position paper".
J Delrieu1, T Voisin, S Andrieu
1Service de médecine interne gériatrique et gérontologie clinique, Gérontopôle, CHU Toulouse, Hôpital Purpan Casselardit, Toulouse, France.
The Journal of Nutrition, Health & Aging
|June 19, 2009
Summary
This study provides updated references for diagnosing and treating mild Alzheimer's disease (AD). It emphasizes the benefits of early diagnosis and current treatment strategies for AD patients.
Area of Science:
- Geriatrics
- Neurology
- Epidemiology
- Psychiatry
- Neuroradiology
- Nuclear Medicine
Background:
- A multidisciplinary group convened under the Societe Francaise de Geriatrie et Gerontologie.
- The group aimed to establish references for diagnosing and treating mild Alzheimer's disease (AD).
- A critical analysis of international literature informed the study's findings.
Purpose of the Study:
- To update knowledge on mild Alzheimer's disease (AD).
- To focus on diagnostic procedures for mild AD.
- To detail specific treatment methods and the advantages of early AD diagnosis.
Main Methods:
- A multidisciplinary expert group was assembled.
- International literature was critically analyzed.
- Discussions were held to define research questions and allocate study drafts.
Main Results:
- The study focused specifically on mild Alzheimer's disease.
- Key areas addressed include diagnostic procedures and treatment options.
- The benefits associated with making an early diagnosis were highlighted.
Conclusions:
- Updated references for mild Alzheimer's disease diagnosis and treatment are provided.
- The importance of early diagnosis in managing Alzheimer's disease is underscored.
- Multidisciplinary collaboration is crucial for advancing Alzheimer's disease care.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.